← Firms / Strategy
Investment strategy
Biotech / Life Sciences VC
Biotech / Life Sciences VC is pursued by 3 firms tracked on DataBane, spanning Venture Capital. Coverage includes 4 funds linked to this strategy, with vintages, sizes and performance where disclosed. Among these profiles reporting in DKK, PensionDanmark has the highest reported AUM at DKK 369B. Profiles below cover each firm's mandate, focus areas, funds and relationships — updated as analysts publish new research.
3
Firms
4
Related funds
1
Asset classes
Asset-class mix
Insight
Most concentrated in Venture Capital (3 of 3 firms). PensionDanmark has the highest reported AUM in this DKK coverage set at DKK 369B.
Firms pursuing this strategy
Reported AUM in DKK; reporting dates can differ.
Geographic exposure
North America14Europe13United States7Asia6South America4France4Germany4United Kingdom4Global4Canada2Africa2Asia Pacific2
Related funds
Recent news
other
PensionDanmark invests in 200 Glostrup rental homes
PensionDanmark · 20/10/2026
other
PensionDanmark and SquareMeter plan conditional Haraldsgave housing project
PensionDanmark · 29/09/2026
other
PensionDanmark acquires Absalons Gaard in Copenhagen
PensionDanmark · 08/09/2026
other
Claus Stampe to leave PensionDanmark at the end of January 2027
PensionDanmark · 03/09/2026
other
PensionDanmark receives European venture investment award
PensionDanmark · 25/08/2026